Case Based Peer Perspectives

Jorge Garcia, MD, FACP, provides insight on the case of a 69-year-old man with mCRPC and assesses the classes of agents currently available as treatment options.

Recommendations for treating a 68-year-old male with mantle cell lymphoma with a BTK inhibitor once he has relapsed on prior therapy.

Cathy Eng, MD, FACP, FASCO, reviews the case of a 68-year-old diagnosed with metastatic NTRK fusion-positive colon cancer and shares treatments options.

Usama Gergis, MD, presents the case of a 61-year old man with GvHD, and provides an overview of available treatment options for similar patients, with consideration of the REACH1, REACH2, and GRAVITAS-301 trial regimens.

Luis Raez, MD, reviews the case of a 67-year-old man with metastatic non-small cell NTRK gene fusion lung cancer.

A 59-Year-Old Woman With HER2+ De Novo Metastatic Breast Cancer

A 59-Year Old Woman With Stage IIIC Ovarian Cancer

A 69-Year Old Man With Metastatic BRAF V600E-Mutated Metastatic NSCLC

A 54-Year-Old Woman With Stage 2 HER2+ Breast Cancer

A 62-Year-Old Woman With Metastatic BRAF V600E-Mutated NSCLC

A 63-Year-Old Woman With Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

A 75-Year-Old Man With Metastatic Castrate-Resistant Prostate Cancer

A 60-Year Old Man With Untreated Stage IV EGFR-Mutated Non-Small Cell Lung Cancer

A 72-Year-Old Man With Symptomatic Follicular Lymphoma

A 62-Year-Old Male With Stage III Non-Small Cell Lung Cancer

A 64-Year-Old Male with Untreated Stage IV EGFR-Mutated NSCLC

A 56-Year-Old Female With Recurrent Ovarian Cancer

TKI in Poor-Risk Advanced Renal Cell Carcinoma

Managing A Case of Heavily Pretreated Recurrent Ovarian Cancer

Rapidly Progressing Acute Myeloid Leukemia

Frontline TKI in Intermediate-Risk Renal Cell Carcinoma

First-Line PARPi Maintenance in Advanced Ovarian Cancer

Transplant-Eligible Newly Diagnosed Multiple Myeloma

Outcomes in Newly Diagnosed Transplant-Ineligible Multiple Myeloma

Improving Overall Survival In Extensive Stage Small Cell Lung Cancer

Follicular Lymphoma: Treating Early Progressors

A 59-Year-Old Man With Relapsed Follicular Lymphoma

Refractory Hepatocellular Carcinoma

Relapsed ALK-Rearranged NSCLC

Optimal Management of Relapsed/Refractory mHCC